###begin article-title 0
Epstein-Barr Virus, Beta-Catenin, and E-cadherin in Gastric Carcinomas
###end article-title 0
###begin p 1
###xml 1262 1263 1262 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 155 173 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 175 178 <span type="species:ncbi:10376">EBV</span>
###xml 358 361 <span type="species:ncbi:10376">EBV</span>
###xml 458 461 <span type="species:ncbi:10376">EBV</span>
###xml 593 596 <span type="species:ncbi:10376">EBV</span>
###xml 1242 1249 <span type="species:ncbi:9606">patient</span>
###xml 1358 1361 <span type="species:ncbi:10376">EBV</span>
Activated beta-catenin is suggested to inhibit NF-kappaB activation, and we previously demonstrated that NF-kappaB nuclear positivity was more frequent in Epstein-Barr virus (EBV)-infected gastric carcinomas. It is controversial that beta-catenin and E-cadherin are prognostic markers in gastric carcinomas. To define a relationship between beta-catenin and EBV, and the prognostic value of beta-catenin and E-cadherin, we analyzed in situ hybridization for EBV-encoded small RNAs, beta-catenin, and E-cadherin immunohistochemistry, and clinicophatological features in 111 gastric carcinomas. EBV infection was detected in seven carcinomas (6.3%); none of seven showed beta-catenin nuclear accumulation, and five out of seven revealed beta-catenin membranous loss or cytoplamic expression. Eighty cases (72.1%) showed beta-catenin alteration; i.e., loss of membrane staining in 65 (58.6%), cytoplasmic expression in 35 (31.5%), and nuclear accumulation in 15 (13.5%). E-cadherin alteration was observed in 34 cases (30.6%) and correlated with beta-catenin alteration. On multivariate analysis, the combined immunoexpression group of beta-catenin nuclear accumulation/ E-cadherin alteration and the advanced TNM cancer stage group showed poor patient's survival (p<0.05). In conclusion, beta-catenin activation through nuclear accumulation hardly occurred in EBV-infected gastric carcinomas. The combined immunoexpression pattern of beta-catenin and E-cadherin can be used as a prognostic marker in gastric carcinomas.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 451 470 451 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 783 784 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 451 470 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 475 493 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Gastric cancer is one of the leading fatal malignancies worldwide (1), and the most common malignancy in Korea (2). Now, gastric cancer has been reported to be the second leading cause of death due to malignancy in Korea, which was the first leading cause before 2005 (2). However, the etiology of gastric cancer has not yet been unveiled completely, and the previous studies have provided evidence that risk factors such as diet, infection including Helicobacter pylori and Epstein-Barr virus, and hereditary trait may be involved in (3). Recently, accumulation of molecular events has been known to be important in the development of gastric cancer (4). Furthermore, these biological markers as well as traditional histopathological parameters can be used as prognostic factors (4-8).
###end p 3
###begin p 4
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 161 179 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 181 184 <span type="species:ncbi:10376">EBV</span>
It was suggested that beta-catenin can regulate NF-kappaB negatively (9), and our previous study revealed that NF-kappaB nuclear positivity was more frequent in Epstein-Barr virus (EBV)-positive gastric carcinomas than conventional gastric carcinomas (10).
###end p 4
###begin p 5
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt</italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt</italic>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt</italic>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Beta-catenin, a 92-kDa protein (11), plays multifunctional roles. First, beta-catenin is a component of the cell-cell adhesion complex, as an E-cadherin/beta-catenin complex. Secondly, beta-catenin acts as a coactivator of transcription factors involved in the Wnt signaling pathway (11). Wnt signaling is mediated by secreted proteins that interact with specific cell-membrane receptors and is involved in the growth and differentiation of cells during development. Wnt pathway dysregulation has been implicated in many cancers (11). Uncontrolled activation of this signaling pathway may induce inappropriate proliferation of target cells and may contribute to the development of malignancy. Dysfunction of this regulatory pathway may result in the accumulation of a hypophosphorylated stable form of beta-catenin in the cytoplasm (11), from whence it translocates to the nucleus, binding to the high mobility group domain factors Tcf/LEF (12) and stimulating transcription of target genes such as c-myc and cyclin D1 (13).
###end p 5
###begin p 6
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
E-cadherin is a 120-kDa transmembrane glycoprotein that is responsible for calcium-dependent intercellular adhesion by homotypic interactions (14), and hence plays a critical role in cancer cell metastasis and invasion because anchorage of cells to substrate is critical for the integrity of many cell types including epithelial cells. Becker et al. first disclosed that E-cadherin is implicated in gastric carcinogenesis (15). Functional cadherin-dependent cell adhesion requires the formation of complexes between E-cadherin and catenins. However, cell growth suppressor activity of E-cadherin is not adhesion-dependent. E-cadherin protein can directly transduce a growth inhibitory signal, through the inhibition of beta-catenin signaling (16).
###end p 6
###begin p 7
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 105 109 <span type="species:ncbi:295399">bata</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 317 321 <span type="species:ncbi:295399">bata</span>
Previous immunohistochemical studies have shown a close relationship between alteration of E-cadherin or bata-catenin and lower 5-yr survival rates in diverse human cancers such as breast, urinary bladder, prostate, and esophagus cancer (17-20). However, there is a conflict concerning the prognostic significance of bata-catenin or E-cadherin in gastric cancer (5-8, 21-23).
###end p 7
###begin p 8
###xml 64 67 <span type="species:ncbi:10376">EBV</span>
###xml 243 246 <span type="species:ncbi:10376">EBV</span>
In the present study, we investigated in situ hybridization for EBV-encoded small RNAs and immunoexpression of beta-catenin and E-cadherin proteins in 111 cases of gastric carcinomas, in order to define a relationship between beta-catenin and EBV and to clarify the impact of beta-catenin or E-cadherin on the prognosis.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and tumor tissue
###end title 10
###begin p 11
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
###xml 546 554 <span type="species:ncbi:9606">patients</span>
The present study was based on data from 111 Korean patients undergoing surgically resection for gastric carcinomas from 1990 to 1994 at the Seoul National University Boramae Hospital. Age, sex, tumor size and location, tumor differentiation according to the WHO classification, Lauren classification, and pathological tumor stage (TNM stage) according to the American Joint Committee on Cancer (AJCC) system were evaluated. Survival data were obtained from hospital records and patients' physicians in charge. The overall survival period of the patients was measured from the date of operation to the date of death or the last follow-up.
###end p 11
###begin title 12
EBER-in situ hybridization
###end title 12
###begin p 13
###xml 774 781 774 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 191 194 <span type="species:ncbi:10376">EBV</span>
###xml 227 230 <span type="species:ncbi:10376">EBV</span>
###xml 427 433 <span type="species:ncbi:9986">rabbit</span>
Three micromete thick sections were cut from each paraffin block, deparaffinized and dehydrated, digested with proteinase K, and hybridized for two hours at 37℃ with a fluorescein-conjugated EBV oligonucleotide probe targeting EBV-encoded RNA (EBER) (Novocastra, Newcastle-upon-Tyne, U.K.). Hybridization products were detected using an alkaline phosphatase-conjugated antibody to fluorescein isothiocyanate (affinity-isolated rabbit F[ab']). 5-Bromo-4-chloro-3-indolylphosphate and nitroblue tetrazolium were used as an enzyme substrate to demonstrate the alkaline phosphatase activity. The slides were counterstained with Mayer's hematoxylin. Using a light microscope, black or dark navy-colored aggregates at the hybridization site were interpreted as positive staining (Fig. 1A). Rare reactive lymphocytes showed a positive signal of EBER, but only signals of EBER within the tumor cells were considered to be positive.
###end p 13
###begin title 14
Immunohistochemistry
###end title 14
###begin p 15
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Tumor tissue was retrieved from formalin-fixed, paraffin-embedded specimen. After the antigen retrieval process by microwave, immunohistochemistry was performed with monoclonal antibodies against E-cadherin (1:100, Zymed Laboratories, San Francisco, CA, U.S.A.) and beta-catenin (1:100, Transduction Laboratories, Lexington, KY, U.S.A.), using avidin-biotin complex method. For an interpretation of immunohistochemical staining, cut-off point was adapted as reported previously (7, 21, 22, 24-26). Those cases with loss of membranous staining in more than 10% of tumor cells were considered to be an altered expression of E-cadherin protein (7, 24, 25). An altered expression of beta-catenin protein was divided into three patterns, that is, loss of membranous staining in more than 10% of tumor cells (7, 24, 25), cytoplasmic expression in any degree of tumor cells (21, 22, 26) and nuclear accumulation in any degree of tumor cells (21, 22, 26) patterns.
###end p 15
###begin title 16
Statistics
###end title 16
###begin p 17
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All statistical analyses were conducted using the SPSS 10.0 statistical software program (SPSS, Chicago, IL, U.S.A.). The chi-square test or Fisher's exact test (two-sided), Pearson correlation (two-tailed), and Kendall's tau-b correlation were applied. The cumulative survival rates were obtained by the Kaplan-Meier analysis, and differences in survival were compared using the log-rank test. Multivariate analysis was performed using the Cox proportional hazards model. Values of p<0.05 were considered to be statistically significant.
###end p 17
###begin title 18
RESULTS
###end title 18
###begin title 19
Cilnicopathological features
###end title 19
###begin p 20
###xml 47 54 47 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 409 410 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 389 396 <span type="species:ncbi:9606">patient</span>
Clinicopathological features are summarized in Table 1 and 2. The follow-up period ranged from 2 to 167 months, with a median of 50 months; thirty-five patients (31.5%) were dead and 76 (68.5%) were alive. Among the clinicopathological features evaluated in the present study, Lauren classification showed correlations with tumor location, lymph node metastasis (pN stage), TNM stage, and patient's survival (p<0.05).
###end p 20
###begin title 21
###xml 0 3 <span type="species:ncbi:10376">EBV</span>
EBV-infected gastric carcinomas
###end title 21
###begin p 22
###xml 55 62 55 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 677 684 677 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 0 3 <span type="species:ncbi:10376">EBV</span>
###xml 77 80 <span type="species:ncbi:10376">EBV</span>
###xml 178 181 <span type="species:ncbi:10376">EBV</span>
###xml 447 450 <span type="species:ncbi:10376">EBV</span>
###xml 616 619 <span type="species:ncbi:10376">EBV</span>
EBV infection was revealed in seven carcinomas (6.3%) (Fig. 1A), and none of EBV-infected gastric carcinomas showed beta-catenin nuclear accumulation. However, five out of seven EBV-infected carcinomas revealed beta-catenin alteration; three cases showed cytoplasmic expression, and two out of these three cases had loss of membranous staining simultaneously. Another two cases revealed loss of membranous staining. Regarding E-cadherin, only one EBV-infected carcinoma disclosed E-cadherin alteration. However, there were no statistical significances in beta-catenin or E-cadherin immunoexpression patterns between EBV-infected gastric carcinomas and non-infected carcinomas (Table 3).
###end p 22
###begin p 23
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 83 90 83 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 4 7 <span type="species:ncbi:10376">EBV</span>
###xml 57 64 <span type="species:ncbi:9606">patient</span>
The EBV infection status showed a marginal impact on the patient outcome (p=0.08) (Table 2) but was not associated with beta-catenin or E-cadherin alteration.
###end p 23
###begin title 24
Expression of beta-catenin and E-cadherin
###end title 24
###begin p 25
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 209 218 209 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B-F</xref>
###xml 323 333 323 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B, E</xref>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
There were no significant relationships between clinicopathological features and immunoexpresssion of beta-catenin or E-cadherin (Table 2, 3). A representative immunohistochemical staining pattern is shown in Fig. 1B-F. In normal gastric epithelium, both E-cadherin and beta-catenin showed cytoplasmic membranous staining (Fig. 1B, E). Eighty cases (72.1%) showed beta-catenin alteration, i.e. loss of membrane staining in 65 cases (58.6%), cytoplasmic expression in 35 cases (31.5%), and nuclear accumulation in 15 cases (13.5%) (Table 1, 2). Regarding concurrent cytoplasmic and nuclear beta-catenin expression, nine of 35 cases displayed both cytoplasmic and nuclear beta-catenin. In six additional cases (5.4%), beta-catenin was seen only in the nuclei, leading to a total of 15 cases (13.5%) with beta-catenin nuclear accumulation. E-cadherin alteration (loss of membrane staining) was observed in 34 cases (30.6%) of gastric carcinomas.
###end p 25
###begin p 26
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
The E-cadherin alteration was statistically significantly correlated with beta-catenin alteration (p=0.003); in particular, with beta-catenin membranous loss or nuclear accumulation (p=0.012 and p=0.040, respectively) (Table 4).
###end p 26
###begin title 27
Survival analyses
###end title 27
###begin p 28
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 65 72 <span type="species:ncbi:9606">patient</span>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
###xml 256 263 <span type="species:ncbi:9606">patient</span>
The beta-catenin nuclear accumulation was associated with a poor patient survival in a subset of Lauren diffuse-type carcinomas. Additionally, in a subset of male patients, beta-catenin nuclear accumulation and E-cadherin alteration were related to a poor patient survival (p<0.05).
###end p 28
###begin p 29
###xml 112 119 112 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 1127 1134 1127 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 483 490 <span type="species:ncbi:9606">patient</span>
###xml 617 624 <span type="species:ncbi:9606">patient</span>
###xml 723 730 <span type="species:ncbi:9606">patient</span>
The combined expression pattern of beta-catenin/E-cadherin was reclassified into four combinations (considering Table 4); the combination of beta-catenin alteration/E-cadherin, the combination of beta-catenin membranous pattern/E-cadherin, the combination of beta-catenin cytoplasmic pattern/E-cadherin, and the combination of beta-catenin nuclear pattern/E-cadherin. On univariate analysis, the combination of beta-catenin nuclear pattern/E-cadherin had a significant impact on the patient survival (p<0.05) (Fig. 2A). In other words, a group with beta-catenin nuclear accumulation/E-cadherin alteration showed poor patient survival. Elaborating on this, in groups of combined beta-catenin nuclear pattern/E-cadherin, the patient survival rate of each group was 63% in beta-catenin nuclear accumulation/E-cadherin alteration, which contrasted with the remaining groups; 29%, 29%, and 21%, in a group with beta-catenin nuclear accumulation/normal E-cadherin, in a group with beta-catenin, no nuclear accumulation/normal E-cadherin, and in a group with beta-catenin, no nuclear accumulation/E-cadherin alteration, respectively (Fig. 2A).
###end p 29
###begin p 30
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">Table 5</xref>
###xml 233 239 233 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2C</xref>
###xml 170 177 <span type="species:ncbi:9606">patient</span>
On multivariate analysis, the combined beta-catenin nuclear pattern/E-cadherin, and cancer stage (TNM classification based on the AJCC system) had significant impacts on patient survival (p=0.008 and p=0.001, respectively) (Table 5, Fig. 2). Besides, beta-catenin nuclear accumulation showed a marginal impact (p=0.077) (Fig. 2C).
###end p 30
###begin title 31
DISCUSSION
###end title 31
###begin p 32
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1346 1347 1346 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 108 111 <span type="species:ncbi:10376">EBV</span>
###xml 350 353 <span type="species:ncbi:10376">EBV</span>
###xml 390 393 <span type="species:ncbi:10376">EBV</span>
###xml 448 451 <span type="species:ncbi:10376">EBV</span>
###xml 1001 1004 <span type="species:ncbi:10376">EBV</span>
###xml 1220 1223 <span type="species:ncbi:10376">EBV</span>
###xml 1445 1448 <span type="species:ncbi:10376">EBV</span>
In the present study, we suggest that beta-catenin activation through nuclear accumulation seldom occurs in EBV-infected gastric carcinomas, although beta-catenin expression can be altered in patterns of membranous loss and cytoplasmic expression. Furthermore, our previous paper showed that NFkappaB nuclear accumulation occurred more frequently in EBV-infected gastric carcinomas than in EBV-negative gastric carcinomas (p<0.05) (10), suggesting EBV-infection could be related to NFkappaB activation. The beta-catenin cytoplasmic stabilization is involved in the first step of beta-catenin activation, and nuclear transport is the second step (27), In the present study, it was not certain whether cytoplasmic expression might be related to activated form of beta-catenin or not, because we have not evaluated the free beta-catenin level in cytoplasm or beta-catenin-dependent gene expression level. However, beta-catenin nuclear accumulation can represent beta-catenin activation. Consequently, in EBV-infected gastric carcinomas, beta-catenin activation through nuclear accumulation hardly occurs, but NF- kappaB could be activated. It is plausible that NFkappaB activation might suppress beta-catenin activation in EBV-infected gastric carcinomas because previous papers suggest that beta-catenin activation can inhibit NFkappaB activation (9). Therefore, a negative crosstalk between beta-catenin and NFkappaB activation seems to exist in EBV-infected gastric carcinomas.
###end p 32
###begin p 33
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 706 707 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1259 1261 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1267 1269 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
In the present study, E-cadherin alteration (loss of membrane staining) was observed in 30.6% and beta-catenin alteration in 72.1% [loss of membrane staining in 58.6%, cytoplasmic expression in 31.5%, and nuclear staining in 13.5%] of gastric carcinomas. The figures of the E-cadherin alteration and beta-catenin nuclear accumulation are almost same as those in the paper by Grabsch et al., 30.7% and 13.2%, respectively (21). Additionally, the figures of the beta-catenin membranous loss, cytoplasmic expression and nuclear accumulation are similar to those in the paper by Nabais et al. (22, 26). Meanwhile, concerning beta-catenin, some studies did not evaluate nuclear accumulation of beta-catenin (5, 6, 8, 23, 28). However, beta-catenin nuclear accumulatin should be evaluated in the study of the Wnt signal activation because beta-catenin translocated into the nucleus is predominantly in an active and oncogenic form (11, 27, 29, 30). The Wnt signal activation induces beta-catenin stabilization and its accumulation in the cytoplasm, and then, beta-catenin is translocated to the nucleus, where it interacts with DNA binding proteins of the T-cell factor-lymphoid enhancer factor (Tcf/LEF) family, causing transcriptional activation of target genes (11, 27, 29, 30), such as c-myc and cyclin D1 oncogenes (13). Moreover, in the present study and others (26), certain cases showed beta-catenin only in the nuclear accumulation pattern, neither in cytoplasmic expression nor membranous loss. Therefore, beta-catenin nuclear accumulation should be assessed necessarily.
###end p 33
###begin p 34
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 131 138 <span type="species:ncbi:9606">patient</span>
###xml 387 394 <span type="species:ncbi:9606">patient</span>
###xml 553 560 <span type="species:ncbi:9606">patient</span>
###xml 709 716 <span type="species:ncbi:9606">patient</span>
In the multivariate survival analysis, a group with combined beta-catenin nuclear accumulation/E-cadherin alteration showed a poor patient survival, compared to the other groups (Fig. 2A). In this combined pattern, oncogenic process by beta-catenin activation and cancer progression due to reduction of the cell-cell adhesion by E-cadherin loss can occur together and end up with a poor patient survival, accordingly. This result might apparently support previous suggestions that the beta-catenin or E-cadherin immunoexpression pattern correlates with patient survival (5-8), but the present study showed that only beta-catenin nuclear accumulation or only E-cadherin alteration had no significant impact on patient survival, or rather a combined pattern of beta-catenin nuclear accunmulation/E-cadherin alteration was an independent prognostic factor.
###end p 34
###begin p 35
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 86 90 <span type="species:ncbi:295399">bata</span>
###xml 644 651 <span type="species:ncbi:9606">patient</span>
###xml 700 708 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 763 770 <span type="species:ncbi:9606">patient</span>
There have been controversies concerning the prognostic significance of E-cadherin or bata-catenin in gastric cancer; that is, Grabash et al. (21), Nabias et al. (22), and Joo et al. (23) showed no prognostic significance in their studies. This discrepancy might be partly due to the interpretation of immunohistochemical staining or case selection bias. First, we can find a fault with ignorance of beta-catenin nuclear accumulation in some papers (5, 6, 8, 23, 28). Secondly, subsets of cases can make wide differences. For example, in the present study, beta-catenin nuclear accumulation or E-cadherin alteration had a significant impact on patient survival in subsets such as Lauren diffuse-type patients and male patients, but a marginal impact in the total patient group as a whole. Additionally, Nabais et al. demonstrated that beta-catenin or E-cadherin did not have a prognostic significance based upon different subsets of gastric carcinomas (22).
###end p 35
###begin p 36
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 305 312 <span type="species:ncbi:9606">patient</span>
Previous studies analyzed the prognostic significance of each protein, beta-catenin or E-cadherin, rather than the combined pattern of beta-catenin/E-cadherin. To the best of our knowledge, there is a study about the combined expression pattern of beta-catenin/E-cadherin, in which it correlated with the patient survival in univariate analysis, but not in multivariate analysis (23), although it could be a critical drawback that beta-catenin nuclear accumulation was not analyzed in their study (23). Besides, the other combined pattern of abnormal E-cadherin/MUC1-positive was suggested to be an unfavorable prognostic factor (8).
###end p 36
###begin p 37
###xml 57 60 <span type="species:ncbi:10376">EBV</span>
In conclusion, beta-catenin expression can be altered in EBV-infected gastric carcinomas, but beta-catenin activation through nuclear accumulation hardly occurrs. The beta-catenin and E-cadherin alterations correlated with each other. The combined beta-catenin and E-cadherin pattern can be used as prognostic markers in Korean gastric carcinomas, and frequent alterations of beta-catenin and E-cadherin proteins are observed.
###end p 37
###begin p 38
###xml 59 104 59 104 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Seoul National University College of Medicine</funding-source>
This study was supported by a research grant funded by the Seoul National University College of Medicine (2005).
###end p 38
###begin article-title 39
Epidemiology of gastric cancer
###end article-title 39
###begin article-title 40
Cancer Registry system in Korea
###end article-title 40
###begin article-title 41
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus and its replication
###end article-title 41
###begin article-title 42
The use of molecular biology in diagnosis and prognosis of gastric cancer
###end article-title 42
###begin article-title 43
###xml 100 107 <span type="species:ncbi:9606">patient</span>
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival
###end article-title 43
###begin article-title 44
###xml 125 132 <span type="species:ncbi:9606">patient</span>
Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival
###end article-title 44
###begin article-title 45
Tumour suppressor gene expression correlates with gastric cancer prognosis
###end article-title 45
###begin article-title 46
Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer
###end article-title 46
###begin article-title 47
###xml 55 60 <span type="species:ncbi:9606">human</span>
beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer
###end article-title 47
###begin article-title 48
###xml 46 64 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas
###end article-title 48
###begin article-title 49
Wnt signaling and cancer
###end article-title 49
###begin article-title 50
Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways
###end article-title 50
###begin article-title 51
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
###end article-title 51
###begin article-title 52
Cadherin cell adhesion receptors as a morphogenetic regulator
###end article-title 52
###begin article-title 53
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
###end article-title 53
###begin article-title 54
E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner
###end article-title 54
###begin article-title 55
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer
###end article-title 55
###begin article-title 56
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
###end article-title 56
###begin article-title 57
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
###end article-title 57
###begin article-title 58
Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
###end article-title 58
###begin article-title 59
Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome
###end article-title 59
###begin article-title 60
Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome
###end article-title 60
###begin article-title 61
Prognostic significance of E-cadherin/catenin complex expression in gastric cancer
###end article-title 61
###begin article-title 62
Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers
###end article-title 62
###begin article-title 63
Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines
###end article-title 63
###begin article-title 64
Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis
###end article-title 64
###begin article-title 65
###xml 87 105 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells
###end article-title 65
###begin article-title 66
Alterations of E-cadherin and beta-catenin in gastric cancer
###end article-title 66
###begin article-title 67
The oncogenic activation of beta-catenin
###end article-title 67
###begin article-title 68
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinomas
###end article-title 68
###begin p 69
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 121 122 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 140 141 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 147 148 147 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 496 497 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 597 598 597 598 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 703 704 703 704 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 861 862 861 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 53 71 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 261 279 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Representative features of in situ hybridization for Epstein-Barr virus (A) and immunohistochemistry for beta-catenin (B-D) and E-cadherin (E-F). (A) Most of cancer cell nuclei reveal strong signals of black or dark navy aggregates on in situ hybridization for Epstein-Barr virus, while normal stroma cell nuclei produce no signal (x200). (B) Beta-catenin shows loss of membranous staining in cancer cells (left 2/3), while preserved membranous staining in normal epithelium (right 1/3) (x100). (C) Beta-catenin reveals cytoplasmic expression without nuclear accumulation in cancer cells (x200). (D) Beta-catenin demonstrates nuclear accumulation in cancer cells without cytoplasmic expression (x400). (E) E-cadherin discloses loss of membranous staining in cancer cells (right 2/3), while preserved membranous staining in normal epithelium (left 1/3) (x200). (F) E-cadherin exhibits well preserved membranous staining in cancer cells (x200).
###end p 69
###begin p 70
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 120 121 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 607 608 607 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 679 680 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 690 691 690 691 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 277 284 <span type="species:ncbi:9606">patient</span>
###xml 661 668 <span type="species:ncbi:9606">patient</span>
###xml 762 769 <span type="species:ncbi:9606">patient</span>
Kaplan-Meier survival plots. Combined immunoexpression of beta-catenin nuclear pattern/E-cadherin (A), TNM tumor stage (B), and beta-catenin nuclear accumulation (C). (A) Group 4 (with a combined pattern of beta-catenin nuclear accumulation/E-cadherin alteration) shows a poor patient survival (p=0.001). Group 1, a group with a combined pattern of beta-catenin no nuclear accumulation/normal E-cadherin; Group 2, beta-catenin nuclear accumulation/normal E-cadherin; Group 3, beta-catenin no nuclear accumulation/E-cadherin alteration; and Group 4, beta-catenin nuclear accumulation/E-cadherin alteration. (B) Advanced TNM tumor stage group has a lower rate of patient survival (p=0.008). (C) Beta-catenin nuclear accumulation group has a marginal impact on the patient survival (p=0.077).
###end p 70
###begin p 71
###xml 21 39 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Relationship between Epstein-Barr virus infection, beta-catenin alteration or E-cadherin alteration, and clinicopathological features in 111 cases of gastric carcinomas
###end p 71
###begin p 72
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*Pathologic tumor stage according to the American Joint Committee on Cancer system.
###end p 72
###begin p 73
Relationship between three altered patterns of beta-catenin expression and clinicopathological features in 111 cases of gastric carcinomas
###end p 73
###begin p 74
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*Pathologic tumor stage according to the American Joint Committee on Cancer system.
###end p 74
###begin p 75
###xml 67 85 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 87 90 <span type="species:ncbi:10376">EBV</span>
Comparison of beta-catenin and E-cadherin immunoexpression between Epstein-Barr virus (EBV)-infected gastric carcinomas and non-infected carcinomas
###end p 75
###begin p 76
Relationship between E-cadherin and beta-catenin expression in 111 cases of gastric carcinomas
###end p 76
###begin p 77
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Multivariate analysis of the prognostic factors for overall survival (Cox proportional hazards model) in the 111 patients with gastric carcinomas
###end p 77
###begin p 78
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*Group 1, a group with combined pattern of beta-catenin, no nuclear accumulation/normal E-cadherin; Group 2, beta-catenin nuclear accumulation/normal E-cadherin; Group 3, beta-catenin, no nuclear accumulation/E-cadherin alteration; Group 4, beta-catenin nuclear accumulation/E-cadherin alteration.
###end p 78
###begin p 79
AJCC, American Joint Committee on Cancer.
###end p 79

